Mike Humphries

Mike Humphries

Company: Takeda Oncology

Job title: US Scientific Director- Lung Cancer

Seminars:

Speaker Q&A 11:30 am

Read more

day: Day One

Efficacy and Safety of Mobocertinib in NSCLC Patients with EGFR Exon 20 Insertions 10:30 am

Overview of EGFR exon20 insertions in NSCLC and how they differ from common sensitizing EGFR mutations Current challenges associated with targeting these alterations and theneed for effective therapies Preclinical and clinical profile of MobocertinibRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.